Evidence map›Paper›PMID 35737924›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

PREOPANC Trial: Survival in the Control Arm and Role of Radiation Need More Explanation.

Ankit Jain, Sivakumar Gananadha, Amy Shorthouse, Desmond Yip

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Ankit JainAnkit Jain, MBBS, MD, DM, DNB, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Sivakumar Gananadha, MBBS, MS, Department of Surgery, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Amy Shorthouse, BSc, BMed (Hons), Department of Radiation Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; and Desmond Yip, MBBS, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia.ORCID 0000-0001-9498-380X
Sivakumar GananadhaAnkit Jain, MBBS, MD, DM, DNB, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Sivakumar Gananadha, MBBS, MS, Department of Surgery, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Amy Shorthouse, BSc, BMed (Hons), Department of Radiation Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; and Desmond Yip, MBBS, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia.ORCID 0000-0003-4603-089X
Amy ShorthouseAnkit Jain, MBBS, MD, DM, DNB, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Sivakumar Gananadha, MBBS, MS, Department of Surgery, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Amy Shorthouse, BSc, BMed (Hons), Department of Radiation Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; and Desmond Yip, MBBS, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia.
Desmond YipAnkit Jain, MBBS, MD, DM, DNB, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Sivakumar Gananadha, MBBS, MS, Department of Surgery, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; Amy Shorthouse, BSc, BMed (Hons), Department of Radiation Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia; and Desmond Yip, MBBS, Department of Medical Oncology, The Canberra Hospital, Garran, ACT, Australia, ANU Medical School, Australian National University, Canberra, ACT, Australia.ORCID 0000-0002-2806-2401

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsHumans

Identifiers

PMID35737924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.